FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma | 079937015 | 70092-225 | 70092-225-37 | Fentanyl Citrate; Ropivacaine Hydrochloride | 500 ug/250 mL; 500 mg/250 mL | 2023-1 | valid | 2026-10-15 | |
| QuVa Pharma | 079937015 | 70092-225 | 70092-225-37 | Fentanyl Citrate; Ropivacaine Hydrochloride | 500 ug/250 mL; 500 mg/250 mL | 2022-2 | valid | 2026-10-15 | |
| QuVa Pharma | 079937015 | 70092-225 | 70092-225-37 | Fentanyl Citrate; Ropivacaine Hydrochloride | 500 ug/250 mL; 500 mg/250 mL | 2022-1 | valid | 2026-10-15 |